HWM
GSK icon

Hohimer Wealth Management’s GSK GSK Stock Holding History

Hohimer Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-59,194
Closed -$2.54M – 234
2024
Q1 		$2.54M Sell
59,194
-443
-0.7% -$18.3K 0.59% 64
2023
Q4 		$2.21M Buy
59,637
+66
+0.1% +$2.37K 0.56% 62
2023
Q3 		$2.16M Sell
59,571
-3,050
-5% -$108K 0.62% 56
2023
Q2 		$2.23M Sell
62,621
-2,373
-4% -$85.1K 0.62% 61
2023
Q1 		$2.31M Buy
64,994
+51,861
+395% +$1.81M 0.67% 58
2022
Q4 		$461K Sell
13,133
-38,534
-75% -$1.28M 0.15% 117
2022
Q3 		$1.52M Buy
51,667
+2,281
+5% +$86.5K 0.49% 73
2022
Q2 		$2.69M Sell
49,386
-7,224
-13% -$399K 0.79% 51
2022
Q1 		$3.08M Buy
56,610
+4,468
+9% +$243K 0.61% 65
2021
Q4 		$2.87M Buy
52,142
+197
+0.4% +$10.2K 0.61% 62
2021
Q3 		$2.48M Buy
51,945
+4,392
+9% +$221K 0.52% 74
2021
Q2 		$2.37M Buy
47,553
+4,804
+11% +$231K 0.48% 81
2021
Q1 		$1.91M Buy
42,749
+9,035
+27% +$410K 0.46% 77
2020
Q4 		$1.55M Sell
33,714
-2,150
-6% -$98.8K 0.41% 77
2020
Q3 		$1.62M Sell
35,864
-370
-1% -$18.5K 0.46% 73
2020
Q2 		$1.85M Sell
36,234
-1,367
-4% -$70.1K 0.64% 52
2020
Q1 		$2M Buy
37,601
+7,364
+24% +$393K 0.85% 37
2019
Q4 		$1.78M Buy
+30,237
New +$1.68M 0.62% 65

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Hohimer Wealth Management's GSK Position: Q2 2024 in Review

Hohimer Wealth Management sold out of GSK (GSK) in Q2 2024, closing a stake of 59,194 shares — an estimated $2.54M sold.

Hohimer Wealth Management first reported a position in GSK in Q4 2019 and held it in 18 quarters. The position peaked at $3.08M in Q1 2022. 884 funds tracked by Wall St. Rank hold GSK as of Q2 2024.

  • Hohimer Wealth Management reported no remaining GSK position as of Q2 2024 after selling out during the quarter.
  • Hohimer Wealth Management sold 59,194 GSK shares in Q2 2024, an estimated $2.54M.
  • Hohimer Wealth Management first reported a position in GSK in Q4 2019 and held it in 18 quarters.
  • Hohimer Wealth Management's GSK position peaked at $3.08M in Q1 2022.
  • 884 funds tracked by Wall St. Rank held GSK as of Q2 2024.

Based on Hohimer Wealth Management's 13F filing for Q2 2024, filed 2 Aug 2024.